venBio Partners LLC

Q1 2025 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    7

  • Value ($000)

    $123,556

  • Date Filed
    05/15/2025
  • Form type
    13F-HR
  • CIK
    0001776382
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

PHARVARIS N V

COM
N69605108
$67.34M
55 %

4,289,304

ALMS
ALMS

ALUMIS INC

COM
022307102
$17.11M
14 %

2,787,398

HRMY
HRMY

HARMONY BIOSCIENCES HLDGS IN

COM
413197104
$16.24M
13 %

489,194

---

ACELYRIN INC

COM
00445A100
$9.40M
8 %

3,806,410

ALXO
ALXO

ALX ONCOLOGY HLDGS INC

COM
00166B105
$6.04M
5 %

9,699,925

LYEL
LYEL

LYELL IMMUNOPHARMA INC

COM
55083R104
$3.82M
3 %

7,102,190

---

ARTIVA BIOTHERAPEUTICS INC

COM
04317A107
$3.60M
3 %

1,198,975

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 7 of 7